US HB6813 | 2021-2022 | 117th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 22 2022 - 25% progression, died in committee
Action: 2022-02-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 22 2022 - 25% progression, died in committee
Action: 2022-02-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.
Title
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.
Sponsors
Rep. William Keating [D-MA] |
History
Date | Chamber | Action |
---|---|---|
2022-02-23 | House | Referred to the Subcommittee on Health. |
2022-02-22 | House | Referred to the House Committee on Energy and Commerce. |
2022-02-22 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/117th-congress/house-bill/6813/all-info |
Text | https://www.congress.gov/117/bills/hr6813/BILLS-117hr6813ih.pdf |